[1]
Daniele, G., Di Maio, M. and Piccirillo, M. 2014. Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer: methodological comment:  . Cancer Breaking News. 2, 1 (Apr. 2014), 35–37.